The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlpha Growth Regulatory News (ALGW)

Share Price Information for Alpha Growth (ALGW)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.25
Bid: 1.10
Ask: 1.40
Change: 0.05 (4.17%)
Spread: 0.30 (27.273%)
Open: 1.20
High: 1.25
Low: 1.20
Prev. Close: 1.20
ALGW Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Business Update - 2022 Focus and the 2B Plan

28 Feb 2022 07:00

RNS Number : 9386C
Alpha Growth PLC
28 February 2022
 

 

The information communicated within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 (as in force in the United Kingdom pursuant to the European Union (Withdrawal) Act 2018). Upon the publication of this announcement, this inside information is now considered to be in the public domain

 

 

Alpha Growth Plc

("Alpha", or the "Company")

 

Periodic Business Update - 2022 Focus and the 2B Plan

 

Alpha Growth Plc (LSE: ALGW and OTCQB: ALPGF), a leading financial services specialist in the growing longevity asset class, is pleased to communicate its future strategy for growth whilst updating shareholders on overall company performance and communication initiatives.

 

The Company's development has been transformational in 2021 and with the new year, the Directors wanted to provide the shareholders with the following details on the Company's focus for 2022 to set the stage for its continued growth.

 

The 2B Plan

 

We are very excited to put forth our future growth strategy - The Alpha Growth 2B Plan.

 

The 2B plan is Alpha Growth's ambitious but achievable objective to be managing over $2bn of AUM by 2025, this will provide the Company with a significant source of predictable and recurring revenue. This significant growth in AUM will be achieved by continuing to execute upon our build and buy strategy, as well as by offering a number of new, complementary and innovative strategies to our clients.

To support our buy strategy, we have an established acquisition methodology with a strong pipeline of targets which will substantially increase AUM. We expect to update our shareholders this quarter on the progress of this part of the strategy.

 

The Company does not anticipate an equity raise to complete any of the current targeted acquisitions and believes that future acquisitions can be supported, where required, by the exercise of the outstanding warrants.

 

To support our build strategy, we will aggressively grow AUM organically by continuing to market our strategies to institutions, family offices and high net worth individuals. However, we also plan to offer our strategies to a wider audience of investors by launching a product with reduced financial entry commitments on both the insurance and fund segments of the Company, we expect this to be a key driver of future fund growth.

 

In addition, our build strategy will be further supported by a number of initiatives to expand our marketing and distribution in both our fund and insurance segments.

 

Further information regarding our 2B strategy will be provided in due course.

 

BlackOak Alpha Growth Fund Update

 

Following on from its previous statements earlier this month on the BlackOak Alpha Growth Fund ("Fund"), the Directors are pleased to report that the Fund has enjoyed a strong start to the year and achieved new subscriptions into the fund in January and February of approximately $4m. This brings our total AUM for the fund closer to $50m and increases the visibility of the fund to a larger investor audience which uses the $50m minimum as a benchmark.

 

Recent market volatility caused by world events further underpins the appeal of a fund which provides returns that are uncorrelated to the stock market. We expect further strong interest moving forward.

 

Insurance Business Update

 

Further to its previous announcement earlier this month, the Company's insurance business, Providence Life Insurance Company Ltd (PLAC) continues to add to the Company's combined assets under management.

 

Private Placement Life Insurance continues to be a highly sought after insurance linked wealth management strategy by ultra-high net worth individuals and family offices. As a segregated account company, PLAC offers private placement life insurance (PPLI) and annuity (PPVA) policies.

 

Since the acquisition, PLAC has put in place the systems and processes for the direct origination of PPLI and PPVA policies. As part of its future growth strategy, PLAC has commenced a plan of distribution for its policies through registered investment advisors and other professionals that advise ultra-high net worth individuals and family offices on PPLI.

 

PLAC will issue its first policy this month for $5m in total premiums. The premiums in a PPLI are essentially the assets under management.

 

Since acquiring PLAC in March 2021, the assets under management in the segregated accounts are over $277m with total assets of approximately $290m and producing total business income, essentially the fees earned on asset management, of circa $1.1m for 2021.

 

Whilst the client base remains steady, due to the more correlated nature of the insurance offering, the value of assets does fluctuate, and the stated figures are just snap shots in time. With the broader market experiencing volatility in the fourth quarter, the figure does represent a slight decrease to where the market was mid 2021. PPLI's are structured for multi decade asset holdings and the AUM will fluctuate over time, as markets recover the AUM will increase.

 

This underpins the Company's strategy of providing different investment options within both the longevity asset sector and insurance linked wealth management sector, investors choose their preferred strategy based upon their investment objectives.

 

Shareholder Communications

 

The Company recognises the importance of good shareholder communications and has launched an initiative to ensure we provide both current and prospective shareholders the information they need, when they need it.

 

This initiative has 5 pillars.

 

1) Explain our company: As Alpha Growth continues to grow and adapt we need to ensure we provide everyone with a complete overview of who we are and what we do as a company.

2) Promote our achievements: We have already achieved a huge amount with lots more to come, we now need to actively promote our achievements to the investment community.

3) Communicate our strategy: We have a well-defined growth strategy; we need to build this into an investment proposition and communicate it to both current and future shareholders.

4) Attract Institutional Investors: Our shareholder base is primarily retail based currently and we believe we can further support the share price by attracting institutional investors onto our share register.

5) Engage our shareholders: We have an engaged and active shareholder base. We want to build upon this by ensuring we provide a platform to give you a voice and to have your questions answered.

 

Please keep checking our Investors Relations page on www.algwplc.com for updates on these 5 pillars.

 

Chairman's statement

 

Gobind Sahney, Executive Chairman, stated "We have been progressing the 2B strategy internally over the last 12 months and are making great progress against our objective of managing over $2bn of AUM by 2025 in both the fund and insurance segments of the business.

 

We are very pleased with the foundational work we have brought to PLAC since the acquisition and it is now well positioned to build its AUM organically, whilst also supporting our buy strategy. Interest in the BlackOak Alpha Growth Fund is at an all-time high, driven by recent world events and investors looking for an asset class which is not impacted by the volatility of stock markets."

 

Gobind continued, "2022 will be yet another transformative year for Alpha Growth and we expect our fund and insurance business to grow substantially. I look forward to keeping our shareholders up-to-date on progress and will provide a further update before the end of Q1."

 

For more information, please visit www.algwplc.com or contact the following:

Alpha Growth Plc

+44 (0) 20 3959 8600

Gobind Sahney, Executive Chairman 

info@algwplc.com

BlackOak Alpha Growth Funds

+1 949-326-9799

www.boagf.com

Arden Partners plc

+44 (0) 20 7614 5900

Ruari McGirr / Alexandra Campbell-Harris (Corporate Finance)

UK Investor Relations - Mark Treharne

ir@algwplc.com

 

About Alpha Growth plc

Specialist in Longevity Assets

Alpha Growth plc is a financial advisory business providing specialist consultancy, advisory, and supplementary services to institutional and qualified investors globally in the multi-billion dollar market of longevity assets. Building on its well-established network, the Alpha Growth Group has a unique position in the longevity asset services and investment business, as a listed entity with global reach. The Group's strategy is to expand its advisory and business services via acquisitions and joint ventures in the UK and the US to attain commercial scale and provide holistic solutions to alternative institutional investors who are in need of specialised skills and unique access to deploy their financial resource in longevity assets.

 

Longevity Assets and Non-correlation

As a longevity asset, it is non-correlated to the real estate, equity capital and commodity markets. Its value is a function of time because as time passes the value gets closer to the face value of the policy. Hence creating a steady increase in the net asset value of the investment. This makes it highly attractive to investors wishing to counteract volatility within an investment portfolio and add yield.

 

Note: The Company only advises on and manages Longevity Assets that originate in the USA where the structured and life settlement market is highly regulated.

 

Forward Looking Statements Disclaimer

Certain statements, beliefs and opinions in this document are forward-looking, which reflect the Company's or, as appropriate, the Company's directors' current expectations and projections about future events. By their nature, forward-looking statements involve a number of risks, uncertainties and assumptions that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements. These risks, uncertainties and assumptions could adversely affect the outcome and financial effects of the plans and events described herein. Forward-looking statements contained in this document regarding past trends or activities should not be taken as a representation that such trends or activities will continue in the future. The Company does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. You should not place undue reliance on forward- looking statements, which speak only as of the date of this document. Readers should not treat the contents of this document as advice relating to legal, taxation or investment matters, and are to make their own assessments concerning these and other consequences, including the merits of information and the risks. Readers of this announcement are advised to conduct their own due diligence and agree to be bound by the limitations of this disclaimer.

 

Important Notice

The content of this announcement has not been approved by an authorised person within the meaning of the Financial Services and Markets Act 2000 (FSMA). This announcement has been issued by and is the sole responsibility of the Company. The information in this announcement is subject to change.

 

About BlackOak Alpha Growth Fund

The Fund was established by two highly experienced longevity asset management companies. The Fund invests in life settlements, is a Cayman LP with a tax efficient Master/Feeder structure in an open-ended format with quarterly redemptions. The Fund seeks to provide well-diversified, non-correlated returns. The Fund aims to achieve this objective through the acquisition of secondary and tertiary Life Settlement policies that will be structured and purchased to mitigate longevity risk and other investment and business risks and where the Company's expertise can add value.

 

ENDS

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDTFMITMTTTBMT
Date   Source Headline
22nd Dec 20239:00 amRNSExpiration of Warrants
13th Dec 20237:00 amRNSAlpha International Life Receives KBRA Rating
14th Nov 20233:36 pmRNSJason Sutherland Receives Industry Recognition
9th Oct 20234:00 pmRNSHolding(s) in Company
9th Oct 20232:43 pmRNSHolding(s) in Company
29th Sep 202311:00 amRNSHalf-year Report
14th Aug 20236:29 pmRNSHolding(s) in Company
19th Jun 20237:00 amRNSResult of AGM
6th Jun 20237:00 amRNSNotice of AGM
15th May 20237:00 amRNSAcquisition of Minority Holding and Share Issuance
3rd May 20237:00 amRNSHolding(s) in Company
2nd May 20237:00 amRNS2022 Annual Report & Financial Statements
15th Mar 20237:00 amRNSWarrant Exercise and Total Voting Rights
6th Mar 20237:00 amRNS2022 Annual Recap and Fund Results
8th Feb 20234:40 pmRNSSecond Price Monitoring Extn
8th Feb 20234:35 pmRNSPrice Monitoring Extension
8th Feb 20231:10 pmRNSHolding(s) in Company
20th Jan 20232:05 pmRNSSecond Price Monitoring Extn
20th Jan 20232:00 pmRNSPrice Monitoring Extension
20th Jan 202311:05 amRNSSecond Price Monitoring Extn
20th Jan 202311:00 amRNSPrice Monitoring Extension
12th Dec 20227:00 amRNSFurther Regarding Havelet Acquisition
6th Dec 20227:00 amRNSCompletion of Share Purchase Acquisition
17th Nov 20227:00 amRNSFinancial Services Company Acquistion
27th Oct 20227:00 amRNSChange of Adviser
26th Oct 20224:41 pmRNSSecond Price Monitoring Extn
26th Oct 20224:36 pmRNSPrice Monitoring Extension
3rd Oct 20224:40 pmRNSSecond Price Monitoring Extn
3rd Oct 20224:35 pmRNSPrice Monitoring Extension
3rd Oct 20222:06 pmRNSSecond Price Monitoring Extn
3rd Oct 20222:00 pmRNSPrice Monitoring Extension
3rd Oct 202211:06 amRNSSecond Price Monitoring Extn
3rd Oct 202211:01 amRNSPrice Monitoring Extension
30th Sep 20227:00 amRNSHalf-year Report
28th Sep 20227:00 amRNSAppointment as Investment Manager/Insurance Update
12th Sep 20222:06 pmRNSSecond Price Monitoring Extn
12th Sep 20222:00 pmRNSPrice Monitoring Extension
9th Sep 20222:06 pmRNSSecond Price Monitoring Extn
9th Sep 20222:00 pmRNSPrice Monitoring Extension
8th Sep 20227:00 amRNSDirector and Personnel Announcement
3rd Aug 20227:00 amRNSHolding(s) in Company
26th Jul 20224:40 pmRNSSecond Price Monitoring Extn
26th Jul 20224:35 pmRNSPrice Monitoring Extension
20th Jun 20224:03 pmRNSResults of the Annual General Meeting
31st May 20227:00 amRNSRelease of 2021 Annual Report
27th Apr 20227:00 amRNSShareholder Information Update
24th Mar 20224:41 pmRNSSecond Price Monitoring Extn
24th Mar 20224:36 pmRNSPrice Monitoring Extension
24th Mar 20222:05 pmRNSSecond Price Monitoring Extn
24th Mar 20222:00 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.